Helix Launches Clinicogenomic Research Access Program
San Mateo, California, USA, November 11, 2026 Helix has launched its Research Access Program, offering selected academic and nonprofit...
Semaglutide
Advertisement
Novo Reports Wegovy Liver Marker Gains in Adults With MASH
Plainsboro, New Jersey, USA, and Bagsværd, Denmark, November 8, 2026 Novo Nordisk has announced encouraging findings from a post-hoc...
Novo Nordisk Reports Real-World Wegovy Benefits in MASH
Plainsboro, New Jersey, USA, and Bagsværd, Denmark, November 6, 2026 Novo Nordisk has announced new real-world clinical findings showing...
Novo Nordisk to Present 26 Obesity Data Abstracts at 2026
PLAINSBORO, New Jersey, and BAGSVÆRD, Denmark, October 29, 2026 Novo Nordisk has announced that it will present new clinical...
Eli Lilly Retatrutide Shows Strong Phase 3 Diabetes Results!
INDIANAPOLIS, October 28, 2026 Eli Lilly and Company has announced positive topline results from its Phase 3 TRANSCEND-T2D-2 clinical...
Advertisements
Novo Nordisk to Present 12 New Liver Research Abstracts
PLAINSBORO, New Jersey, and BAGSVÆRD, Denmark, October 28, 2026 Novo Nordisk has announced that it will present 12 new...
Novo Nordisk to Present New Wegovy Liver Research
Plainsboro, New Jersey, United States, and Bagsværd, Denmark, October 28, 2026 Novo Nordisk has announced plans to present 12...
Vanda Reports Positive Phase 3 Results for NEREUS
Washington, D.C., U.S., October 27, 2026 Vanda Pharmaceuticals Inc. has announced positive Phase 3 clinical trial results for NEREUS™...
Kither Biotech Doses First Patients in KIT2014 COPD Trial
TURIN, Italy — September 29, 2026 Kither Biotech Pty Ltd and Kither Biotech Srl announced that the first patients...
Caspian Unveils KO-7246 Preclinical Diabetes Data at EASD
SAN DIEGO — September 29, 2026 Caspian Therapeutics and Kura Oncology announced new preclinical data for KO-7246, an investigational,...
Advertisement
